-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Akoya Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2020 to Q1 2025.
- Akoya Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was $48K, a 23.8% decline year-over-year.
- Akoya Biosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2025 was $131K, a 77% increase year-over-year.
- Akoya Biosciences, Inc. annual Income Tax Expense (Benefit) for 2024 was $146K, a 265% increase from 2023.
- Akoya Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $40K, a 67.5% decline from 2022.
- Akoya Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $123K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)